Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 24,177 shares at $111.02 ($2.7M) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($2.7M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.01 | 258 | $28K | 1.0% |
| 2 | $110.08 | 2,072 | $228K | 8.5% |
| 3 | $110.08 | 2,072 | $228K | 8.5% |
| 4 | $110.15 | 5,545 | $611K | 22.7% |
| 5 | $111.02 | 3,102 | $344K | 12.8% |
| 6 | $111.02 | 3,102 |
| $344K |
| 12.8% |
| 7 | $111.85 | 2,263 | $253K | 9.4% |
| 8 | $111.85 | 2,263 | $253K | 9.4% |
| 9 | $112.95 | 367 | $41K | 1.5% |
| 10 | $114.25 | 389 | $44K | 1.6% |
| 11 | $115.15 | 344 | $40K | 1.5% |
| 12 | $116.42 | 1,195 | $139K | 5.2% |
| 13 | $116.42 | 1,195 | $139K | 5.2% |
| 14 | $117.03 | 10 | $1K | 0.0% |
| Total | $111.46 avg | 24,177 | $2.7M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |